Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1995 1
1996 1
1997 1
2000 1
2002 3
2003 1
2004 1
2011 1
2013 1
2014 1
2015 3
2016 2
2017 2
2018 1
2019 1
2020 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Idiopathic giant cell myocarditis and cardiac sarcoidosis.
Blauwet LA, Cooper LT. Blauwet LA, et al. Heart Fail Rev. 2013 Nov;18(6):733-46. doi: 10.1007/s10741-012-9358-3. Heart Fail Rev. 2013. PMID: 23111533 Review.
Idiopathic giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare disorders that cause cardiomyopathy, often with ventricular arrhythmias or heart block. ...
Idiopathic giant cell myocarditis (GCM) and cardiac sarcoidosis (CS) are rare disorders that cause cardiomyopath …
Small steps for idiopathic giant cell myocarditis.
Shih JA, Shih JA. Shih JA, et al. Curr Heart Fail Rep. 2015 Jun;12(3):263-8. doi: 10.1007/s11897-015-0260-x. Curr Heart Fail Rep. 2015. PMID: 25895034 Review.
Idiopathic giant cell myocarditis (IGCM) is a rare disease causing progressive myocarditis characterized by myocardial necrosis and giant cells. ...
Idiopathic giant cell myocarditis (IGCM) is a rare disease causing progressive myocarditis characterized by myoc …
Giant cell myocarditis.
Cooper LT Jr, Berry GJ, Rizeq M, Schroeder JS. Cooper LT Jr, et al. J Heart Lung Transplant. 1995 Mar-Apr;14(2):394-401. J Heart Lung Transplant. 1995. PMID: 7779862
The clinical and pathologic features of lymphocytic myocarditis have been described in several recent publications, but the features of idiopathic giant cell myocarditis have not been adequately addressed. METHODS AND RESULTS: We describe five patients …
The clinical and pathologic features of lymphocytic myocarditis have been described in several recent publications, but the features of i …
Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25-Year Nationwide Cohorts.
Nordenswan HK, Lehtonen J, Ekström K, Räisänen-Sokolowski A, Mäyränpää MI, Vihinen T, Miettinen H, Kaikkonen K, Haataja P, Kerola T, Rissanen TT, Kokkonen J, Alatalo A, Pietilä-Effati P, Utriainen S, Kupari M. Nordenswan HK, et al. J Am Heart Assoc. 2021 Mar 16;10(6):e019415. doi: 10.1161/JAHA.120.019415. Epub 2021 Mar 4. J Am Heart Assoc. 2021. PMID: 33660520 Free PMC article.
Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling.
Lassner D, Kühl U, Siegismund CS, Rohde M, Elezkurtaj S, Escher F, Tschöpe C, Gross UM, Poller W, Schultheiss HP. Lassner D, et al. Eur Heart J. 2014 Aug 21;35(32):2186-95. doi: 10.1093/eurheartj/ehu101. Epub 2014 Mar 24. Eur Heart J. 2014. PMID: 24667923
AIMS: Improvement of clinical diagnostics of idiopathic giant cell myocarditis (IGCM) and cardiac sarcoidosis (CS), two frequently fatal human myocardial diseases. ...
AIMS: Improvement of clinical diagnostics of idiopathic giant cell myocarditis (IGCM) and cardiac sarcoidosis (C …
Recognition and optimum management of myocarditis.
Caforio AL, McKenna WJ. Caforio AL, et al. Drugs. 1996 Oct;52(4):515-25. doi: 10.2165/00003495-199652040-00005. Drugs. 1996. PMID: 8891464 Review.
Although at present the use of immunosuppressive therapy cannot be recommended on a routine basis, the recent Myocarditis Treatment Trial, where an aetiologically heterogeneous patient population was treated without significant adverse effects, provides some rationale for applyin …
Although at present the use of immunosuppressive therapy cannot be recommended on a routine basis, the recent Myocarditis Treatment Trial, w …
Giant cell myocarditis presenting with acute heart failure.
Kasouridis I, Majo J, MacGowan G, Clark AL. Kasouridis I, et al. BMJ Case Rep. 2017 May 22;2017:bcr2017219574. doi: 10.1136/bcr-2017-219574. BMJ Case Rep. 2017. PMID: 28536222 Free PMC article. Review.
Idiopathic giant cell myocarditis (GCM) is a rare and rapidly progressing form of myocarditis predominantly affecting younger people. ...
Idiopathic giant cell myocarditis (GCM) is a rare and rapidly progressing form of myocarditis predominantly affe …
Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.
Cooper LT Jr, Berry GJ, Shabetai R. Cooper LT Jr, et al. N Engl J Med. 1997 Jun 26;336(26):1860-6. doi: 10.1056/NEJM199706263362603. N Engl J Med. 1997. PMID: 9197214 Free article.
BACKGROUND: Idiopathic giant-cell myocarditis is a rare and frequently fatal disorder. We used a multicenter data base to define the natural history of giant-cell myocarditis and the effect of treatment. METHODS: We identified 63 patients with idiop …
BACKGROUND: Idiopathic giant-cell myocarditis is a rare and frequently fatal disorder. We used a multicenter dat …
Idiopathic giant cell myocarditis in childhood: A case report.
Pehlivan S, Akçan R, Heybet ER, Cavlak M, Pehlivan A. Pehlivan S, et al. Leg Med (Tokyo). 2016 Mar;19:93-5. doi: 10.1016/j.legalmed.2015.08.001. Epub 2015 Aug 7. Leg Med (Tokyo). 2016. PMID: 26275338
Idiopathic giant cell myocarditis is a rare entity of unknown origin, which causes sudden death in more than half of the affected patients. ...Here we present a rare case of childhood idiopathic giant cell myocarditis. A 10- …
Idiopathic giant cell myocarditis is a rare entity of unknown origin, which causes sudden death in more than hal …
23 results